These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 477842)

  • 1. The effects of dopaminergic blocking agents on the glucose tolerance test in 6 humans and 6 dogs.
    Lechin F; Coll-García E; van der Dijs B; Bentolila A; Peña F; Rivas C
    Experientia; 1979 Jul; 35(7):886-7. PubMed ID: 477842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal pharmacomanometry and glucose tolerance: two kinds of dopaminergic mechanisms in the human.
    Lechin F; van der Dijs B
    Acta Gastroenterol Latinoam; 1981; 11(2):247-59. PubMed ID: 7039203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal pharmacomanometry and glucose tolerance: evidence for two antagonistic dopaminergic mechanisms in the human.
    Lechin F; van der Dijs B
    Biol Psychiatry; 1981 Oct; 16(10):969-86. PubMed ID: 7306619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of captivity on glucose tolerance in dogs.
    Lechin F; Coll-Garcia E; van der Dijs B; Bentolila A; Peña F; Rivas C
    Experientia; 1979 Jul; 35(7):876-7. PubMed ID: 573210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of haloperidol, sulpiride and SCH 23390 on passive avoidance learning in mice.
    Ichihara K; Nabeshima T; Kameyama T
    Eur J Pharmacol; 1988 Jul; 151(3):435-42. PubMed ID: 3063548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic haloperidol and sulpiride treatment on rat nigral GABA content.
    Rampello L; Giammona G; Patti F; Reggio A; Nicoletti F; Di Giorgio RM; Condorelli DF
    Boll Soc Ital Biol Sper; 1981 Aug; 57(15):1608-11. PubMed ID: 7306401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of long-term treatment with haloperidol and sulpiride on different types of dopaminergic receptors.
    Trabucchi M; Memo M; Battaini F; Reggiani A; Spano PF
    Adv Biochem Psychopharmacol; 1980; 24():275-81. PubMed ID: 7405667
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of subchronic haloperidol and sulpiride on regional brain dopamine metabolism in the rat.
    Lindefors N; Sharp T; Ungerstedt U
    Eur J Pharmacol; 1986 Oct; 129(3):401-4. PubMed ID: 3780852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the antipsychotic agent amisulpride on glucose lowering and insulin secretion.
    Roix JJ; DeCrescenzo GA; Cheung PH; Ciallella JR; Sulpice T; Saha S; Halse R
    Diabetes Obes Metab; 2012 Apr; 14(4):329-34. PubMed ID: 22059694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intercentral interactions during typical and atypical neuroleptics administration].
    Kachalova LM; Popova NS
    Biull Eksp Biol Med; 1999 May; 127(5):512-5. PubMed ID: 10399568
    [No Abstract]   [Full Text] [Related]  

  • 11. Antidepressant effect of carbamazepine--the role of dopaminergic and noradrenergic agents.
    Słuzewska A; Chodera A
    Pol J Pharmacol Pharm; 1992; 44(3):209-15. PubMed ID: 1470559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral supersensitivity to methamphetamine following chronic treatment with (--)-sulpiride in the rat.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Boll Soc Ital Biol Sper; 1981 Feb; 57(4):401-6. PubMed ID: 7195265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of carbidine, sulpiride and haloperidol on levels of monoamines and their metabolites in the brain structures of rats].
    Miroshnichenko II; Kudrin VS; Raevskiĭ KS
    Farmakol Toksikol; 1988; 51(2):26-9. PubMed ID: 2897932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of peripheral dopamine receptor and alpha-adrenoceptor blocking activity of sulpiride.
    Barrett RJ; Ginos JZ; Lokhandwala MF
    Eur J Pharmacol; 1982 Apr; 79(3-4):273-81. PubMed ID: 6124431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of the antipsychotics sulpiride or risperidone in rats. I: bodyweight, food intake, body composition, hormones and glucose tolerance.
    Baptista T; Araujo de Baptista E; Ying Kin NM; Beaulieu S; Walker D; Joober R; Lalonde J; Richard D
    Brain Res; 2002 Dec; 957(1):144-51. PubMed ID: 12443990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations.
    Costall B; Naylor RJ
    Br J Pharmacol; 1995 Dec; 116(7):2989-99. PubMed ID: 8680734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging brain gene expression profiles by antipsychotics: region-specific action of amisulpride on postsynaptic density transcripts compared to haloperidol.
    de Bartolomeis A; Marmo F; Buonaguro EF; Rossi R; Tomasetti C; Iasevoli F
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1516-29. PubMed ID: 23357084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential blocking effects of several dopamine receptor antagonists for peripheral pre- and postsynaptic dopamine receptors in the anesthetized dog.
    Shepperson NB; Duval N; Massingham R; Langer SZ
    J Pharmacol Exp Ther; 1982 Jun; 221(3):753-61. PubMed ID: 6123587
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (-)-Sulpiride activates the firing rate and tyrosine hydroxylase activity of dopaminergic neurons in unanesthetized rats.
    Mereu G; Casu M; Gessa GL
    Brain Res; 1983 Mar; 264(1):105-10. PubMed ID: 6133578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.